CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 175 filers reported holding CASTLE BIOSCIENCES INC in Q1 2021. The put-call ratio across all filers is 5.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $654,200 | -79.2% | 38,733 | -83.1% | 0.00% | -75.0% |
Q2 2023 | $3,151,361 | -17.8% | 229,691 | +36.1% | 0.01% | -29.4% |
Q1 2023 | $3,833,591 | +34750.8% | 168,732 | +33850.1% | 0.02% | – |
Q2 2022 | $11,000 | -47.6% | 497 | +6.7% | 0.00% | – |
Q1 2022 | $21,000 | +10.5% | 466 | +7.9% | 0.00% | – |
Q4 2021 | $19,000 | -42.4% | 432 | -13.4% | 0.00% | – |
Q3 2021 | $33,000 | +3.1% | 499 | +15.0% | 0.00% | – |
Q2 2021 | $32,000 | +966.7% | 434 | +864.4% | 0.00% | – |
Q1 2021 | $3,000 | – | 45 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |